Design Therapeutics, Inc.
NASDAQ:DSGNBiotechnology
Healthcare
$9.84 +1.59%
+$0.19 today
- Market cap
- $630.12M
- Beta
- 1.66
- P/E (TTM)
- -10.7
- EPS (TTM)
- -$1.13
52W Low $3.33High $17.25
Volume 0.29M
Average 0.74M
Price history
Design Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+29.64%
Period high
$15.94
Period low
$7.34
Latest
$9.84
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| EFFECT | Nov 12, 2026 | Nov 13, 2026 | |
| S-3 | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 424B5 | Nov 4, 2026 | Nov 4, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 3, 2026 | Aug 3, 2026 | |
| 10-Q | Aug 3, 2026 | Aug 3, 2026 | |
| 4 | Jun 11, 2026 | Jun 11, 2026 | |
| 4 | Jun 11, 2026 | Jun 11, 2026 | |
| 4 | Jun 11, 2026 | Jun 11, 2026 | |
| 4 | Jun 11, 2026 | Jun 11, 2026 | |
| 4 | Jun 11, 2026 | Jun 11, 2026 | |
| 8-K | Jun 11, 2026 | Jun 11, 2026 |
Competitors
Who does Design Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about DSGN's filings, answered from its disclosures.
What is the latest DSGN filing?
The latest filing shown is EFFECT dated Nov 12, 2026.
How many recent filings does DSGN have?
Intrinsic Alpha currently shows 20 recent filings for DSGN.
Continue the stock analysis
Jump to another research area for this company.